BioStone > Veterinary Biologics and Vaccine Solutions > Vaccine Adjuvants and Bacterial Antigens
Vaccine Adjuvants and Bacterial Antigens
BioStone Animal Health offers veterinary vaccine adjuvants, inactivated bacterial cultures, and biological components for vaccine development, contract manufacturing, and commercial supply.
Our portfolio is available to qualified U.S. and international vaccine manufacturers, animal-health companies, research organizations, and commercial partners.
BioStone welcomes discussions involving:
- Contract manufacturing
- Formulation and compatibility evaluation
- Bacterin development
- U.S. and international distribution
VACCINE ADJUVANTS
BioStone offers multiple veterinary vaccine adjuvant systems for use with bacterial and other vaccine antigens.
| Product | Type | Intended Species | Typical Application | U.S. Availability | International Availability |
| AlGel | Aluminum hydroxide | All species | Mix at approximately 2–10% with antigens | Available | Available |
| Adjuvant C | Polymer solution | Cattle, Small ruminants, Swine | Mix at approximately 20% with antigens | Available | Available |
| Adjuvant E | Oil-in-water emulsion | Cattle, Small ruminants, Swine, Poultry | Mix at approximately 20–50% with antigens | Available | Available |
| Adjuvant EMBA | Oil-in-water emulsion | Cattle, Small ruminants, Swine | Mix at approximately 20–50% with antigens | Available | Available |
POTENTIAL ADJUVANT BENEFITS
- Multiple adjuvant technologies for different vaccine formulations
- Options suitable for livestock and poultry applications
- Flexible inclusion levels based on formulation requirements Available for technical evaluation and commercial supply
ADJUVANT TECHNICAL EVALUATION
Adjuvant performance may vary depending on:
- Antigen composition
- Target species
- Dose and inclusion level
- Route of administration
- Desired immune response
- Finished-product formulation
BioStone can support technical discussions regarding candidate selection, formulation considerations, and potential evaluation plans.
Discuss a Collaboration
BACTERIAL ANTIGENS
Inactivated cultures for veterinary bacterin production
BioStone can provide selected inactivated bacterial cultures for manufacturers.
| Biological Component | Material Type | Intended Species | Application | U.S. Availability | International Availability |
| Mycoplasma spp. | Inactivated culture | Cattle, Swine, Poultry | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Mannheimia haemolytica | Inactivated culture | Cattle, Small ruminants | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Pasteurella multocida | Inactivated culture | Cattle, Swine, Poultry | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Histophilus somni | Inactivated culture | Cattle | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Streptococcus spp. | Inactivated culture | Equine, Swine | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Rhodococcus equi | Inactivated culture | Equine | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Corynebacterium pseudotuberculosis | Inactivated culture | Small ruminants, Equine | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Moraxella spp. | Inactivated culture | Cattle | Bacterin production | Contract manufacturing | Available, subject to import requirements |
| Clostridium spp. | Inactivated culture | Cattle, Small ruminants, Equine | Bacterin production | Contract manufacturing | Available, subject to import requirements |
POTENTIAL APPLICATIONS
BioStone’s bacterial cultures and biological components may support:
- Monovalent or multivalent veterinary bacterins
- Contract-manufacturing programs
- Partner-specific vaccine development
- Expansion of bacterial disease coverage
- U.S. and international commercialization projects
Availability may depend on the organism, intended use, production volume, destination country, contractual terms, and regulatory or import requirements.
DISCUSS A COLLABORATION
Companies interested in learning more about BioStone’s vaccine adjuvants and bacterial antigens are invited to contact BioStone Animal Health.